These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19641864)

  • 1. Mesenchymal stem cells targeting the GVHD.
    Wang L; Zhao RC
    Sci China C Life Sci; 2009 Jul; 52(7):603-9. PubMed ID: 19641864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
    Baron F; Lechanteur C; Willems E; Bruck F; Baudoux E; Seidel L; Vanbellinghen JF; Hafraoui K; Lejeune M; Gothot A; Fillet G; Beguin Y
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):838-47. PubMed ID: 20109568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel therapies for graft versus host disease with a focus on cell therapies.
    Zeiser R; Ringden O; Sadeghi B; Gonen-Yaacovi G; Segurado OG
    Front Immunol; 2023; 14():1241068. PubMed ID: 37868964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Potential of Mesenchymal Stromal Cells as Treatment for Severe Steroid-Refractory Acute Graft-Versus-Host Disease: A Critical Review of the Literature.
    Munneke JM; Spruit MJ; Cornelissen AS; van Hoeven V; Voermans C; Hazenberg MD
    Transplantation; 2016 Nov; 100(11):2309-2314. PubMed ID: 26714122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of acute graft versus host disease (GvHD).
    Bacigalupo A; Palandri F
    Hematol J; 2004; 5(3):189-96. PubMed ID: 15167903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stromal cells for graft-versus-host disease.
    Tolar J; Villeneuve P; Keating A
    Hum Gene Ther; 2011 Mar; 22(3):257-62. PubMed ID: 21288086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells transplantation in hematological patients with acute graft-versus-host disease: characteristics and risk factors for infectious complications.
    Stoma I; Karpov I; Krivenko S; Iskrov I; Milanovich N; Koritko A; Uss A
    Ann Hematol; 2018 May; 97(5):885-891. PubMed ID: 29380038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
    Tian Y; Deng YB; Huang YJ; Wang Y
    Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice.
    Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM
    Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats.
    Kitazawa Y; Li XK; Xie L; Zhu P; Kimura H; Takahara S
    Cell Transplant; 2012; 21(2-3):581-90. PubMed ID: 22793067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal photopheresis in prevention and treatment of acute GVHD.
    Kitko CL; Levine JE
    Transfus Apher Sci; 2015 Apr; 52(2):151-6. PubMed ID: 25748231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remestemcel-L, the first cellular therapy product for the treatment of graft-versus-host disease.
    Daly A
    Drugs Today (Barc); 2012 Dec; 48(12):773-83. PubMed ID: 23243634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in poor graft function after allogeneic hematopoietic stem cell transplantation upon administration of mesenchymal stem cells from third-party donors: a pilot prospective study.
    Liu X; Wu M; Peng Y; Chen X; Sun J; Huang F; Fan Z; Zhou H; Wu X; Yu G; Zhang X; Li Y; Xiao Y; Song C; Xiang AP; Liu Q
    Cell Transplant; 2014; 23(9):1087-98. PubMed ID: 23294601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mesenchymal stem cells for treatment of graft-versus-host disease].
    Najima Y
    Rinsho Ketsueki; 2017; 58(12):2440-2449. PubMed ID: 29332881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mesenchymal stem cells for treatment of steroid-resistant chronic graft-versus-host disease].
    Zhang LS; Liu QF; Huang K; Zhang Y; Fan ZP; Huang SL
    Zhonghua Nei Ke Za Zhi; 2009 Jul; 48(7):542-6. PubMed ID: 19957792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditioned medium from human palatine tonsil mesenchymal stem cells attenuates acute graft‑vs.‑host disease in mice.
    Cho KA; Kim YH; Park M; Kim HJ; Woo SY; Park JW; Ryu KH
    Mol Med Rep; 2019 Jan; 19(1):609-616. PubMed ID: 30431127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced efficacy of mesenchymal stromal cells in preventing graft-versus-host disease in an in vivo model of haploidentical bone marrow transplant with leukemia.
    Oviedo A; Yañez R; Colmenero I; Aldea M; Rubio A; Bueren JA; Lamana ML
    Cell Transplant; 2013; 22(8):1381-94. PubMed ID: 23044223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.